Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
1992-8-24
|
pubmed:abstractText |
Binding of [3H]-SQ 29,548 was characterized to soluble thromboxane A2/prostaglandin H2 (TP) receptors from human platelet membranes as a means of examining ligand-receptor interactions outside the lipophilic environment of the cell membrane. Kinetic determination revealed a rate of ligand-receptor association of 1.4 x 10(7) +/- 0.2 M-1 x min-1 and a rate of dissociation of 0.5 +/- 0.07 min-1. The resultant equilibrium affinity constant was 36.3 +/- 5.8 nM. Saturation binding analysis revealed a single class of [3H]-SQ 29,548 binding sites with an affinity constant of 39.7 +/- 4.3 nM and a B(max) of 1735.7 +/- 69.1 fmol/mg protein. Specific [3H]-SQ 29,548 binding was inhibited by specific TP receptor antagonists and agonists in a rank order of potency similar to that seen in platelet membranes: SQ 33,961 much greater than SQ 29,548 greater than BM 13,505 greater than or equal to U 46619 greater than BM 13,177. PGD2, PGE2 and PGI2 did not appreciably inhibit the specific binding of [3H]-SQ 29,548. These data indicate that [3H]-SQ 29,548 binding to soluble human platelet TP receptors was specific, saturable, and reversible.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Hydrazines,
http://linkedlifedata.com/resource/pubmed/chemical/Prostaglandin Antagonists,
http://linkedlifedata.com/resource/pubmed/chemical/Prostaglandins H,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Prostaglandin,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Thromboxane,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Thromboxane A2...,
http://linkedlifedata.com/resource/pubmed/chemical/SQ 29548,
http://linkedlifedata.com/resource/pubmed/chemical/Thromboxane A2
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0024-3205
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
51
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
431-7
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:1386132-Blood Platelets,
pubmed-meshheading:1386132-Cell Membrane,
pubmed-meshheading:1386132-Humans,
pubmed-meshheading:1386132-Hydrazines,
pubmed-meshheading:1386132-Prostaglandin Antagonists,
pubmed-meshheading:1386132-Prostaglandins H,
pubmed-meshheading:1386132-Receptors, Prostaglandin,
pubmed-meshheading:1386132-Receptors, Thromboxane,
pubmed-meshheading:1386132-Receptors, Thromboxane A2, Prostaglandin H2,
pubmed-meshheading:1386132-Solubility,
pubmed-meshheading:1386132-Thromboxane A2
|
pubmed:year |
1992
|
pubmed:articleTitle |
Characterization of binding of a specific antagonist, [3H]-SQ 29,548, to soluble thromboxane A2/prostaglandin H2 (TP) receptors in human platelet membranes.
|
pubmed:affiliation |
Department of Cardiovascular Biochemistry, Bristol-Myers Squibb Pharmaceutical Research Institute, Princeton, N.J. 08543.
|
pubmed:publicationType |
Journal Article
|